Moringa Oleifera Leaves for Use in Clinical Studies.
New method for extracting the beneficial compounds in Moringa identified
Cold (isothiocyanates-rich) moringa leaf powder teas will have the greatest chemoprotection potential.
A team of researchers from the Cullman Chemoprotection Center at Johns Hopkins University and the Universidad Nacional Autónoma de México led by Dr. Jed Fahey has developed a convenient and household-friendly method of extracting the beneficial compounds present in Moringa, a tropical plant native to central and southern Asia. The findings were published on July 9 in “Plant Food, Nutrition, and Human Health,” a special issue of the journal Nutrients.
Posted July 12, 2019 by Teresa Johnson
“The cold teas delivered a known dose of isothiocyanate. For clinical studies this is actually better because we know exactly what we’re delivering to people,” said Fahey. “We think this will be a great delivery vehicle in clinical trials involving children who have autism.”
Identifying the efficiency of these phytochemical extraction methods for creating teas from moringa will facilitate the delivery of moringa tea to both adults and children in future clinical trials to gauge their effects on a wide range of health conditions, including autism, diabetes, and hypertension.